David Birnie, Rob S B Beanlands, Pablo Nery, Shawn D Aaron, Daniel A Culver, Robert A DeKemp, Lorne Gula, Andrew Ha, Jeffery S Healey, Yuko Inoue, Mark A Judson, Daniel Juneau, Kengo Kusano, Russell Quinn, Lena Rivard, Mustafa Toma, Amanda Varnava, George Wells, Melissa Wickremasinghe, Jordana Kron
UNLABELLED: Approximately 5% of patients with sarcoidosis have clinically manifest cardiac involvement. Clinical features of Cardiac Sarcoidosis are dependent on the location, extent, and activity of the disease. First line therapy is usually with prednisone and this is recommended based on clinician experience, expert opinion and small observational cohorts. There are no published clinical trials in cardiac sarcoidosis and multiple experts in the field have called for randomized clinical trials to answer important patient care questions...
February 2020: American Heart Journal